BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11451177)

  • 1. Efficacy and limitations of a specific immunotherapy in chronic hepatitis B.
    Pol S; Nalpas B; Driss F; Michel ML; Tiollais P; Denis J; Brécho C;
    J Hepatol; 2001 Jun; 34(6):917-21. PubMed ID: 11451177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lack of effect of therapeutic vaccination with a pre-S2/S HBV vaccine in the immune tolerant phase of chronic HBV infection.
    Yalcin K; Danis R; Degertekin H; Alp MN; Tekes S; Budak T
    J Clin Gastroenterol; 2003 Oct; 37(4):330-5. PubMed ID: 14506391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic vaccination in the immunotolerant phase of children with chronic hepatitis B infection.
    Dikici B; Kalayci AG; Ozgenc F; Bosnak M; Davutoglu M; Ece A; Ozkan T; Ozeke T; Yagci RV; Haspolat K
    Pediatr Infect Dis J; 2003 Apr; 22(4):345-9. PubMed ID: 12690275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection.
    Dikici B; Bosnak M; Ucmak H; Dagli A; Ece A; Haspolat K
    J Gastroenterol Hepatol; 2003 Feb; 18(2):218-22. PubMed ID: 12542609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of chronic hepatitis B by anti HBV vaccine.
    Pol S; Couillin I; Michel ML; Driss F; Nalpas B; Carnot F; Berthelot P; Bréchot C
    Acta Gastroenterol Belg; 1998; 61(2):228-33. PubMed ID: 9658616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific hepatitis B vaccine therapy in inactive HBsAg carriers: a randomized controlled trial.
    Yalcin K; Acar M; Degertekin H
    Infection; 2003 Aug; 31(4):221-5. PubMed ID: 14562945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of immunotherapy with vaccination against hepatitis B virus on virus B multiplication].
    Pol S; Driss F; Carnot F; Michel ML; Berthelot P; Brechot C
    C R Acad Sci III; 1993 Jul; 316(7):688-91. PubMed ID: 8019891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
    Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
    J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase IIb trial of
    Yang FQ; Rao GR; Wang GQ; Li YQ; Xie Y; Zhang ZQ; Deng CL; Mao Q; Li J; Zhao W; Wang MR; Han T; Chen SJ; Pan C; Tan DM; Shang J; Zhang MX; Zhang YX; Yang JM; Chen GM
    World J Gastroenterol; 2017 Jan; 23(2):306-317. PubMed ID: 28127204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum HBeAg sero-conversion correlated with decrease of HBsAg and HBV DNA in chronic hepatitis B patients treated with a therapeutic vaccine.
    Wang XY; Zhang XX; Yao X; Jiang JH; Xie YH; Yuan ZH; Wen YM
    Vaccine; 2010 Nov; 28(51):8169-74. PubMed ID: 20937312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: a randomized study.
    Gaggar A; Coeshott C; Apelian D; Rodell T; Armstrong BR; Shen G; Subramanian GM; McHutchison JG
    Vaccine; 2014 Sep; 32(39):4925-31. PubMed ID: 25045824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice.
    Yoon SK; Seo YB; Im SJ; Bae SH; Song MJ; You CR; Jang JW; Yang SH; Suh YS; Song JS; Kim BM; Kim CY; Jeong SH; Sung YC
    Liver Int; 2015 Mar; 35(3):805-15. PubMed ID: 24620920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of therapeutic vaccination for the treatment of chronic hepatitis B virus infection.
    Lee YB; Lee JH; Kim YJ; Yoon JH; Lee HS
    J Med Virol; 2015 Apr; 87(4):575-82. PubMed ID: 25611586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific T cell immune response in chronic hepatitis B patients treated with different doses of recombinant hepatitis B vaccine].
    Xu QH; Zhang XH; Xie DY; Li JG; Chong YT; Yang L; Lu WL; Gao ZL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Dec; 21(4):334-6. PubMed ID: 18322594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral effects of anti-HBs immunoglobulin and vaccine on HBs antigen seroclearance for chronic hepatitis B infection.
    Tsuge M; Hiraga N; Uchida T; Kan H; Miyaki E; Masaki K; Ono A; Nakahara T; Abe-Chayama H; Zhang Y; Naswa MG; Kawaoka T; Miki D; Imamura M; Kawakami Y; Aikata H; Ochi H; Hayes CN; Chayama K
    J Gastroenterol; 2016 Nov; 51(11):1073-1080. PubMed ID: 26943168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
    Ren F; Hino K; Yamaguchi Y; Funatsuki K; Hayashi A; Ishiko H; Furutani M; Yamasaki T; Korenaga K; Yamashita S; Konishi T; Okita K
    J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
    Boni C; Janssen HLA; Rossi M; Yoon SK; Vecchi A; Barili V; Yoshida EM; Trinh H; Rodell TC; Laccabue D; Alfieri A; Brillo F; Fisicaro P; Acerbi G; Pedrazzi G; Andreone P; Cursaro C; Margotti M; Santoro R; Piazzolla V; Brunetto MR; Coco B; Cavallone D; Zhao Y; Joshi A; Woo J; Lau AH; Gaggar A; Subramanian GM; Massetto B; Fung S; Ahn SH; Ma X; Mangia A; Ferrari C
    Gastroenterology; 2019 Jul; 157(1):227-241.e7. PubMed ID: 30930022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo immunization by vaccine therapy following virus suppression by lamivudine: a novel approach for treating patients with chronic hepatitis B.
    Horiike N; Fazle Akbar SM; Michitaka K; Joukou K; Yamamoto K; Kojima N; Hiasa Y; Abe M; Onji M
    J Clin Virol; 2005 Feb; 32(2):156-61. PubMed ID: 15653419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of chronic hepatitis B by anti HBV vaccine.
    Pol S
    Biomed Pharmacother; 1995; 49(3):105-9. PubMed ID: 7647280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.